The prescriber must hold an active state medical license (a DEA registration is required only for controlled substances, which GLP-1 medications are not), but no additional GLP-1 certification or subspecialty credential is mandated by law
This minimizes exposure to air every time you use a dose and keeps the rest of the supply fresh
Supplements / powders sold for oral use are often inappropriately used for injection and may carry bacterial/ endotoxin contamination
Powders over 12 oz (350 mL) in a carry-on must be placed in a separate bin for screening
Retrieved June 8, 2025, from Santen, R
Retatrutide Powder represents a revolutionary advancement in metabolic therapeutics as the world's most potent triple-agonist API targeting GLP-1, GIP, and glucagon receptors simultaneously